Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics

Samankaltaisia teoksia

• Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding
  Tekijä: Shah, Nirav R., et al.
  Julkaistu: (2019)
• Comparable Population Pharmacokinetics and Pharmacodynamic Breakpoints of Cefpirome in Cystic Fibrosis Patients and Healthy Volunteers
  Tekijä: Bulitta, J. B., et al.
  Julkaistu: (2011)
• Population Pharmacokinetic Comparison and Pharmacodynamic Breakpoints of Ceftazidime in Cystic Fibrosis Patients and Healthy Volunteers
  Tekijä: Bulitta, J. B., et al.
  Julkaistu: (2010)
• Evaluation by Monte Carlo Simulation of the Pharmacokinetics of Two Doses of Meropenem Administered Intermittently or as a Continuous Infusion in Healthy Volunteers
  Tekijä: Krueger, Wolfgang A., et al.
  Julkaistu: (2005)
• Oral Bioavailability and Plasma Disposition of Pefloxacin in Healthy Broiler Chickens
  Tekijä: Martínez, María-Aránzazu, et al.
  Julkaistu: (2017)